Related Experiment Videos
Immunological escape mechanisms in pancreatic carcinoma
H Ungefroren1, M Voss, W V Bernstorff
1Research Unit for Molecular Oncology, Clinic for General Surgery and Thoracic Surgery, Christian Albrechts University, Kiel, Germany.
Abstract:
Malignancies have developed several strategies to evade immune surveillance. We have investigated pancreatic cancer cell lines and pancreatic cancer surgical specimens to evaluate possibilities of tumor escape in the Fas system, and local immune suppression. Despite Fas expression the majority of cell lines was resistant to Fas-mediated apoptosis. The Fas-associated phosphatase-1 is a strong candidate to confer Fas resistance in pancreatic cancer cells. In addition, all investigated pancreatic cancer cell lines and cancer specimens expressed Fas ligand. Fas ligand was functional in cancer cell lines as shown by coculture assays of pancreatic cancer cell lines with Jurkat cells as targets. Additional local immune suppression was demonstrated by loss of T-cell receptor/CD3-zeta chain of pancreatic cancer infiltrating T-lymphocytes. We conclude that these tumor escape mechanisms may contribute to the poor prognosis of pancreatic cancer but also represent targets for new treatment modalities.
Insights
Pancreatic cancer cells resist immune attack by evading Fas-mediated apoptosis and suppressing local immune cells. These tumor escape mechanisms in pancreatic cancer offer potential therapeutic targets.
Area of Science:
- Oncology
- Immunology
Background:
- Malignancies develop immune evasion strategies.
- Pancreatic cancer is known for its poor prognosis and resistance to therapies.
Purpose of the Study:
- To investigate tumor escape mechanisms in pancreatic cancer.
- To evaluate resistance to Fas-mediated apoptosis and local immune suppression in pancreatic cancer.
Main Methods:
- Analysis of pancreatic cancer cell lines and surgical specimens.
- Assessing Fas expression and resistance to Fas-mediated apoptosis.
- Investigating Fas ligand functionality via co-culture assays.
- Evaluating T-cell receptor/CD3-zeta chain expression in tumor-infiltrating T-lymphocytes.
Main Results:
- Most pancreatic cancer cell lines were resistant to Fas-mediated apoptosis despite Fas expression.
- Fas-associated phosphatase-1 is identified as a potential mediator of Fas resistance.
- Pancreatic cancer cells and specimens expressed functional Fas ligand.
- Pancreatic tumors exhibited local immune suppression through loss of T-cell receptor/CD3-zeta chain in T-lymphocytes.
Conclusions:
- Pancreatic cancer utilizes Fas resistance and local immune suppression for immune evasion.
- These mechanisms contribute to the poor prognosis of pancreatic cancer.
- Identified escape mechanisms represent potential targets for novel pancreatic cancer treatments.